Physician profile
Cassandra Ferragamo
NPI 1902465032
$806.19
in general payments reported to CMS, 2019-2025
8 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $251 · 2024: $146 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.02 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $162.13 | 2021 | |
| Terumo Medical Corporation | $134.31 | 2025 | Azur Cx Detachable |
| Astrazeneca Pharmaceuticals LP | $126.04 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $112.54 | 2025 | Adstiladrin |
| Medical Device Business Services, INC. | $98.00 | 2024 | |
| Solventum Corporation | $30.66 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Urgo Medical North America, LLC | $17.51 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Ferragamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.